| DB ID | MyCo_3464 |
| Title | Development and evaluation of a whole blood-based approach for flow cytometric quantification of CD154+ mould-reactive T cells |
| Year | 2020 |
| PMID | 31095327 |
| Fungal Diseases involved | Invasive mycoses |
| Associated Medical Condition | None |
| Genus | Rhizopus |
| Species | arrhizus |
| Organism | Rhizopus arrhizus |
| Ethical Statement | Written informed consent, ap- proved by the Ethics Committee of the University of Wuerzburg was obtained (approval numbers 105/15 and 42/17). |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | CD154 |
| Biomarker Full Name | CD154 |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | USA |
| Cohort | None |
| Cohort No. | None |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Analytic |
| Analysis Method | Flow Cytometry Analysis |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Flow Cytometry Analysis |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
